Intrinsic Value

The intrinsic value of BioMaxima SA (944) under the Base Case is 2.599 EUR per share. Compared with the current market price of 1.556 EUR, the stock appears Undervalued by 40% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
€2.599
Undervaluation 40%
Intrinsic Value
Price €1.556

BioMaxima SA is cheaper than usual. It was this cheap or cheaper on just 12% of days in the past 5 years.

Alert me when BioMaxima SA is below its intrinsic value
Today €1.299 · 16.5% below the current price
Alternatives to BioMaxima SA

Fundamental Analysis

What BioMaxima Does

Health Care

BioMaxima SA makes diagnostic products used by laboratories, hospitals, and medical clinics to test patient samples. Its core business is in vitro diagnostics, which means tests done on blood, urine, and other samples outside the body to help detect disease, monitor health, and support medical decisions. The company sells reagent kits, diagnostic panels, and related laboratory materials that doctors and labs use every day.

Headquarters
Poland PL
IPO date
Jun 8, 2010
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue Research

Decided on BioMaxima? Get an email when BioMaxima SA reaches the price you’d buy at. Free with an account.

Other BioMaxima listings

What is the Intrinsic Value of one BioMaxima SA stock?

The intrinsic value for BioMaxima SA (944) under the Base Case is 2.599 EUR.

Is BioMaxima SA stock undervalued or overvalued?

Compared with the current market price of 1.556 EUR, the stock appears Undervalued by 40% .

How reliable are our estimates? See how past valuations played out
Back to Top